---
title: "Aptevo Therapeutics Appoints Mary J. Janatpour, Ph.D., as Senior Vice President & Chief Scientific Officer | APVO Stock News"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/287914731.md"
description: "Aptevo Therapeutics Appoints Mary J. Janatpour, Ph.D., as Senior Vice President & Chief Scientific Officer | APVO Stock News"
datetime: "2026-05-28T04:05:31.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/287914731.md)
  - [en](https://longbridge.com/en/news/287914731.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/287914731.md)
generator: "portal-rs"
---

# Aptevo Therapeutics Appoints Mary J. Janatpour, Ph.D., as Senior Vice President & Chief Scientific Officer | APVO Stock News

Aptevo Therapeutics Appoints Mary J. Janatpour, Ph.D., as Senior Vice President & Chief Scientific Officer | APVO Stock News

### Related Stocks

- [APVO.US](https://longbridge.com/en/quote/APVO.US.md)
- [IBB.US](https://longbridge.com/en/quote/IBB.US.md)
- [FBT.US](https://longbridge.com/en/quote/FBT.US.md)
- [LABU.US](https://longbridge.com/en/quote/LABU.US.md)
- [BBH.US](https://longbridge.com/en/quote/BBH.US.md)
- [PBE.US](https://longbridge.com/en/quote/PBE.US.md)
- [IBBQ.US](https://longbridge.com/en/quote/IBBQ.US.md)
- [SBIO.US](https://longbridge.com/en/quote/SBIO.US.md)
- [XBI.US](https://longbridge.com/en/quote/XBI.US.md)

## Related News & Research

- [BIONATION 2026 to Bring Canada’s Life Sciences Sector Together in Ottawa](https://longbridge.com/en/news/299236957.md)
- [Aptevo Reports 93% Clinical Benefit Rate with Mipletamig Triplet in Difficult-to-Treat TP53-Mutated Frontline AML | APVO Stock News](https://longbridge.com/en/news/297911849.md)
- [Aptevo Therapeutics announces special shareholder meeting](https://longbridge.com/en/news/297564634.md)
- [Aptevo Provides 2Q26 Business Update and Reports Second Quarter Financial Results | APVO Stock News](https://longbridge.com/en/news/295932565.md)
- [Cancer Vaccines Market Anticipates Impressive Growth Trajectory at a CAGR of 36% During the Forecast Period (2026-2036) | DelveInsight](https://longbridge.com/en/news/299655817.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**